Mingtao Ao

442 total citations
20 papers, 352 citations indexed

About

Mingtao Ao is a scholar working on Molecular Biology, Organic Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, Mingtao Ao has authored 20 papers receiving a total of 352 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Organic Chemistry and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in Mingtao Ao's work include Nuclear Receptors and Signaling (5 papers), HIV/AIDS drug development and treatment (4 papers) and HIV Research and Treatment (3 papers). Mingtao Ao is often cited by papers focused on Nuclear Receptors and Signaling (5 papers), HIV/AIDS drug development and treatment (4 papers) and HIV Research and Treatment (3 papers). Mingtao Ao collaborates with scholars based in China, United States and Rwanda. Mingtao Ao's co-authors include Meijuan Fang, Xiao Dong Chen, Zhenhua Wu, Zhenqing Hou, Zhongquan Qi, Nini Li, Li Yang, Donghui Li, Xiaoming Zheng and Junjie Xia and has published in prestigious journals such as Scientific Reports, Chemical Engineering Journal and British Journal of Cancer.

In The Last Decade

Mingtao Ao

19 papers receiving 348 citations

Peers

Mingtao Ao
Guojun Pan China
Ying Zheng China
Debasmita Dutta United States
Yongxiang Zheng China
Jianli Liu China
Raghuvir H. Gaonkar India
Anshumali Awasthi India
Hyo-Kyung Han United States
I-Lin Lu Taiwan
Rohit Bavi India
Guojun Pan China
Mingtao Ao
Citations per year, relative to Mingtao Ao Mingtao Ao (= 1×) peers Guojun Pan

Countries citing papers authored by Mingtao Ao

Since Specialization
Citations

This map shows the geographic impact of Mingtao Ao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingtao Ao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingtao Ao more than expected).

Fields of papers citing papers by Mingtao Ao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mingtao Ao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingtao Ao. The network helps show where Mingtao Ao may publish in the future.

Co-authorship network of co-authors of Mingtao Ao

This figure shows the co-authorship network connecting the top 25 collaborators of Mingtao Ao. A scholar is included among the top collaborators of Mingtao Ao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mingtao Ao. Mingtao Ao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Chen, Jun, Wenbin Hong, Mingtao Ao, et al.. (2024). Discovery of a novel exceptionally potent and orally active Nur77 ligand NB1 with a distinct binding mode for cancer therapy. Acta Pharmaceutica Sinica B. 14(12). 5493–5504. 4 indexed citations
3.
Qian, Yuqing, Jiayi Li, Huanwen Chen, et al.. (2023). Discovery of 4-((3,4-dichlorophenyl)amino)-2-methylquinolin-6-ol derivatives as EGFR and HDAC dual inhibitors. European Journal of Pharmacology. 960. 176114–176114. 7 indexed citations
4.
Chang, Chenli, Fengming He, Mingtao Ao, et al.. (2023). Inhibition of Nur77 expression and translocation by compound B6 reduces ER stress and alleviates cigarette smoke-induced inflammation and injury in bronchial epithelial cells. Frontiers in Pharmacology. 14. 1200110–1200110. 11 indexed citations
5.
Cao, Yin, Chaojie Wang, Guo-Sheng Hu, et al.. (2023). The novel CDK9 inhibitor, XPW1, alone and in combination with BRD4 inhibitor JQ1, for the treatment of clear cell renal cell carcinoma. British Journal of Cancer. 129(12). 1915–1929. 8 indexed citations
6.
7.
Qian, Yuqing, Mingtao Ao, Boqun Li, et al.. (2022). Design and synthesis of N-(1-(6-(substituted phenyl)-pyridazin-3-yl)-piperidine-3-yl)-amine derivatives as JMJD6 inhibitors. Bioorganic Chemistry. 129. 106119–106119. 3 indexed citations
8.
Ao, Mingtao, Jun Wu, Yin Cao, et al.. (2022). The synthesis of PROTAC molecule and new target KAT6A identification of CDK9 inhibitor iCDK9. Chinese Chemical Letters. 34(4). 107741–107741. 12 indexed citations
9.
Ao, Mingtao, Fei Yu, Yixiang Li, et al.. (2021). Carrier-free nanoparticles of camptothecin prodrug for chemo-photothermal therapy: the making, in vitro and in vivo testing. Journal of Nanobiotechnology. 19(1). 350–350. 42 indexed citations
10.
Ao, Mingtao, Xianwen Hu, Yuqing Qian, et al.. (2021). Discovery of new chalone adamantyl arotinoids having RXRα-modulating and anticancer activities. Bioorganic Chemistry. 113. 104961–104961. 5 indexed citations
11.
Wu, Jun, Hongyu Hu, Mingtao Ao, et al.. (2021). Design, synthesis, and biological evaluation of 5-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)-1H-Indole-2-Carbohydrazide derivatives: the methuosis inducer 12A as a Novel and selective anticancer agent. Journal of Enzyme Inhibition and Medicinal Chemistry. 36(1). 1435–1452. 9 indexed citations
12.
Fang, Hua, Jianyu Zhang, Mingtao Ao, et al.. (2020). Synthesis and discovery of ω-3 polyunsaturated fatty acid- alkanolamine (PUFA-AA) derivatives as anti-inflammatory agents targeting Nur77. Bioorganic Chemistry. 105. 104456–104456. 16 indexed citations
13.
14.
Yu, Fei, Nini Li, Mingtao Ao, et al.. (2019). Imaging-guided synergistic targeting-promoted photo-chemotherapy against cancers by methotrexate-conjugated hyaluronic acid nanoparticles. Chemical Engineering Journal. 380. 122426–122426. 35 indexed citations
15.
Ao, Mingtao, Yuqing Qian, Bowen Tang, et al.. (2018). Design, synthesis, and biological evaluation of AV6 derivatives as novel dual reactivators of latent HIV-1. RSC Advances. 8(31). 17279–17292. 5 indexed citations
16.
Wu, Jun, Mingtao Ao, Rui Shao, et al.. (2017). A chalcone derivative reactivates latent HIV-1 transcription through activating P-TEFb and promoting Tat-SEC interaction on viral promoter. Scientific Reports. 7(1). 10657–10657. 16 indexed citations
17.
Hu, Hongyu, Mingtao Ao, Bowen Tang, et al.. (2017). Synthesis and biological evaluation of 1-(2-(adamantane-1-yl)-1H-indol-5-yl)-3-substituted urea/thiourea derivatives as anticancer agents. RSC Advances. 7(81). 51640–51651. 28 indexed citations
18.
Tang, Bowen, Boqun Li, Yuqin Qian, et al.. (2017). The molecular mechanism of hPPARα activation. RSC Advances. 7(28). 17193–17201. 5 indexed citations
19.
Yu, Fei, Mingtao Ao, Xiaoming Zheng, et al.. (2017). PEG–lipid–PLGA hybrid nanoparticles loaded with berberine–phospholipid complex to facilitate the oral delivery efficiency. Drug Delivery. 24(1). 825–833. 98 indexed citations
20.
Hu, Hongyu, Jun Wu, Mingtao Ao, et al.. (2016). Synthesis, structure–activity relationship studies and biological evaluation of novel 2,5‐disubstituted indole derivatives as anticancer agents. Chemical Biology & Drug Design. 88(5). 766–778. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Guojun Pan Breakdown of academic impact, for papers by Ying Zheng Breakdown of academic impact, for papers by Debasmita Dutta Breakdown of academic impact, for papers by Yongxiang Zheng Breakdown of academic impact, for papers by Jianli Liu Breakdown of academic impact, for papers by Raghuvir H. Gaonkar Breakdown of academic impact, for papers by Anshumali Awasthi Breakdown of academic impact, for papers by Hyo-Kyung Han Breakdown of academic impact, for papers by I-Lin Lu Breakdown of academic impact, for papers by Rohit Bavi
Rankless by CCL
2026